Clinical Trials Logo

Clinical Trial Summary

Benign pigmented lesions as solar lentigines are a common finding in Caucasian individuals. Their removal may be requested for aesthetic reasons.

The goal of the study is comparing the efficacy and tolerance of two different therapy modalities established for treating solar lentigines.

The right back of the hand side will be treated with the Q-switched SINON Rubin 694nm Laser, the left back of the hand side with a hydrochinon containing bleaching cream (Pigmanorm® cream).

The investigators estimate that a physical therapy with a Q-switched Rubin laser system is more effective in the removal of solar lentigines than a topical chemical therapy with a hydrochinon containing bleaching cream.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02153697
Study type Interventional
Source University of Zurich
Contact
Status Completed
Phase N/A
Start date March 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT04583852 - Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines N/A
Completed NCT00386204 - Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types Phase 2
Completed NCT01885871 - Laser Removal of Age (Sun) Spots on Hands N/A
Recruiting NCT01249469 - Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011 N/A
Completed NCT01778179 - A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy N/A